Fu-Xi Li

机构：Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University

发表论文 12 篇 · 总被引 108 次 · h-index 3

代表论文

• MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway (2019 · Journal of Experimental & Clinical Cancer Research · 被引 45)
• N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance (2024 · Oncogene · 被引 35)
• CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy (2024 · Cancer Letters · 被引 23)
• Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma (2024 · World Journal of Gastrointestinal Oncology · 被引 3)
• [Blocking programmed death-ligand 1 attenuates maturation inhibition of dendritic cells by co-cultured breast cancer cells]. (2018 · PubMed · 被引 1)
• [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. (2013 · PubMed · 被引 1)